Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1470 of 5804
-
Food boxes and health coaching aim to tame diabetes in the deep south
Disease control OngoingBrief Summary: The FREEDOM study aims to develop a scalable intervention to improve type 2 diabetes mellitus control in low-income Black adults in the Deep South. The intervention targets social determinants of health (SDoH) such as reduced healthcare access, poverty, transporta…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Which stent graft shrinks aneurysms best? new trial aims to find out.
Disease control Recruiting nowThe purpose of this trial is to generate clinical evidence related to key performance outcomes of Endurant II/IIs Stent Graft Systems verses Gore Excluder / Excluder Conformable AAA Endoprosthesis in subjects with Abdominal Aortic Aneurysms. Subjects are randomized and imaging co…
Phase: NA • Sponsor: Medtronic Cardiovascular • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New gel takes on pink eye in Head-to-Head trial
⭐️ CURE ⭐️ CompletedA Phase 2, Multi-center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis
Phase: PHASE2 • Sponsor: IVIEW Therapeutics Inc. • Aim: ⭐️ CURE ⭐️
Last updated Jun 27, 2026 08:01 UTC
-
Cord blood cells take on scleroderma in new trial
Disease control Recruiting nowThe purpose of this study is to test the safety and efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (UCMSC) for the treatment of Systemic Sclerosis (SSc).
Phase: PHASE1, PHASE2 • Sponsor: Marie Hudson, MD • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can coaching families boost heart failure pill-taking?
Disease control Recruiting nowPeople with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality of life. In the proposed intervention, nurses will use easy-to-understand language to coach patients and their care partn…
Phase: NA • Sponsor: Jia-Rong Wu • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New immunotherapy combo shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis is a two-arm, open-label, phase Ib single-site study with expansion cohorts testing the addition of mosunetuzumab to intensive platinum-based salvage chemotherapy in patients with relapsed/refractory aggressive B cell lymphoma. The hypothesis of this study is that mosunetuzu…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Lung cancer patients get second chance with triple therapy combo
Disease control OngoingStill many advanced non-small cell lung cancer (NSCLC) patients do not benefit from PD-(L)1 inhibition or will eventually develop progression through secondary resistance. Inhibition of CTLA-4, application of radiotherapy together with PD-1 inhibition showed synergistic effects a…
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Couples checkup may lower suicide risk in struggling veterans
Symptom relief Recruiting nowThis study compares two approaches to working with Veterans that have a mix of mental health and relationship concerns in primary care. One approach is a 3-session couple-based program called the Brief Relationship Checkup (BRC). BRC has shown promise improving relationship healt…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Exercise before ovarian cancer surgery may reduce frailty and boost recovery
Symptom relief Recruiting nowIndividuals with ovarian cancer have very poor survival rates. This is because the cancer is not usually detected until it has reached advanced stages. How long an individual survives also is determined by the cancer treatment they receive. Although there are best treatment pract…
Phase: NA • Sponsor: Nova Scotia Health Authority • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Experimental pill targets toxic fat buildup in rare genetic disease
Disease control CompletedThis research study will determine whether orally administered ADX-629 is safe and has biochemical efficacy in participants with Sjögren-Larsson syndrome (SLS), a rare inherited disorder of fatty aldehyde metabolism The disease is caused by bi-allelic mutations in ALDH3A2, which …
Phase: PHASE1, PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Mushroom extract shows promise against stubborn HPV
Disease control CompletedThis is a retrospective, multicenter, observational study evaluating real-world HPV-DNA clearance in women with documented persistent high-risk HPV infection lasting at least six months. Clinical data were retrospectively collected from medical records of women managed in routine…
Sponsor: Liaquat University of Medical & Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI could help decide best treatment for ovarian cancer
Diagnosis Recruiting nowPREDAtOOR is a pilot study and this study aims at improving the selection of the best treatment strategy for patients with advanced ovarian cancer by using Camera Vision (CV) to predict outcomes of cyto reduction at the time of Diagnostic laparoscopy.
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
Allergy shots may unlock better asthma control by targeting hidden immune signals
Disease control CompletedAsthma is a chronic heterogeneous inflammatory airway disease affecting millions worldwide and remains a major global health burden. Despite advances in pharmacological therapy, a substantial proportion of patients continue to experience uncontrolled symptoms due to persistent ai…
Phase: NA • Sponsor: Mansoura University Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New test could tailor chemo for bile duct cancer patients after surgery
Disease control Recruiting nowThis research aims to study the effect of postoperative adjuvant therapy with a MiniPDX drug sensitivity test for biliary tract cancer.
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 26, 2026 13:37 UTC
-
Could a transplant drug tame thyroid eye disease?
Disease control Recruiting nowThe purpose of this study is to determine whether Sirolimus is more effective and burdened with less side effects than conventional treatment with corticosteroids in patients with active thyroid eye disease.
Phase: PHASE2 • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Dialysis breakthrough? two simple Add-Ons may cut deadly complications
Disease control CompletedBackground and Purpose: This clinical study aims to explore and validate two innovative treatment strategies to address two major challenges faced by patients on maintenance hemodialysis (uremia): the high incidence of cardiovascular and cerebrovascular complications and the comm…
Phase: NA • Sponsor: Suzhou Municipal Hospital of Anhui Province • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
VR therapy offers new hope for 'Sea Legs' disorder
Symptom relief Recruiting nowMal de Débarquement Syndrome (MdDS) is an under-recognized balance disorder, which is manifested by persistent false sensations of oscillatory self-motion (rocking/swaying) and/or pulling in a specific direction (gravitational pull). Patients with MdDS typically experience additi…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Glow-in-the-Dark dye could make Children's tumor surgery safer and more effective
Disease control Recruiting nowThe goal of this prospective randomized controlled study is to explore the role of indocyanine green-fluorescence imaging in management of cystic lymphatic malformation.. To clarify the application value of indocyanine green-fluorescence imaging in both diagnosis and treatment of…
Phase: NA • Sponsor: Nanjing Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Exercise may cut fall risk in osteoporosis
Disease control CompletedPostmenopausal osteoporosis increases the risk of fragility fractures, and falls are a major modifiable pathway leading to fracture. This single-blind randomized controlled pilot trial evaluated whether a supervised progressive strength and balance exercise program reduced fall o…
Phase: NA • Sponsor: Instituto Nacional de Rehabilitacion • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New combo therapy shows promise for tough bile duct cancer
Disease control Recruiting nowAfter the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:37 UTC